04:55 PM EDT, 08/13/2024 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said late Tuesday it has raised $316.25 million from the offering of 2.25% convertible senior notes due 2029, including the full exercise of the initial purchasers' option to buy additional notes.

ANI said it will use $40.6 million from the proceeds to fund the cost of entering into the capped call transactions, with the remaining funds to help repay its senior secured term loan facility.